Orchid Chemicals and Pharmaceuticals and Merck & Co, Inc have entered into research collaboration and license agreement focused on the discovery, development and commercialization of novel agents for the treatment of bacterial and fungal infections.
The details can be read here.
No comments:
Post a Comment